About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Natco to Withdraw Breast Cancer Drug from Indian Market

by Rajashri on July 18, 2009 at 9:37 PM
Font : A-A+

 Natco to Withdraw Breast Cancer Drug from Indian Market

The Indian Health Regulator Drug Controller General of India (DCGI) has asked Natco Pharma to stop marketing the breast cancer drug 'Albupax'. The company said it was stopping production of the drug after research indicated that it may cause liver damage.

As per DCGI office, we have stopped marketing the product in the interim," Natco Pharma said.
"Natco maintains its product passes all quality parameters. The test methods used to test a nano technology product are complex."

Advertisement

Natco initially introduced the drug in India last October and had tied up with Dr Reddy's Laboratories for a US launch.

The company also indicated that the revenues generated by the drug were insignificant and that its removal from the market would not affect its bottom line.




Source: Medindia
RAS
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
World Heart Day in 2022- Use Heart for Every Heart
Anemia among Indian Women and Children Remains a Cause of Concern- National Family Health Survey-5
H1N1 Influenza Prevention in Children: What Parents Need to Know
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Women and Cancer Drug Toxicity Breast Biopsy Pagets disease of the breast Mastitis Cancer and Homeopathy Signature Drug Toxicity Breast Cancer Facts Cancer Facts Cancer 

Most Popular on Medindia

Daily Calorie Requirements Vent Forte (Theophylline) Diaphragmatic Hernia Pregnancy Confirmation Calculator Color Blindness Calculator Drug Interaction Checker Noscaphene (Noscapine) Post-Nasal Drip Blood - Sugar Chart Sanatogen
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

Natco to Withdraw Breast Cancer Drug from Indian Market Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests